Clinical characteristics and outcomes in patients with t(8;21) acute myeloid leukemia in Japan-Reference-Cited by-同舟云学术

Clinical characteristics and outcomes in patients with t(8;21) acute myeloid leukemia in Japan

Published:2007-08-16 Issue:2 Volume:22 Page:428-432
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Narimatsu H,Yokozawa T,Iida H,Tsuzuki M,Hayakawa M,Takeo T,Iino M,Ichihashi T,Kato C,Sawamoto A,Sao H,Yanada M,Emi N,kiyoi H,Yamaguchi T,Naoe T,Suzuki R,Sugiura I

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404905.pdf

Reference8 articles.

1. Ferrara F, Del Vecchio L . Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity. Haematologica 2002; 87: 306–319.

2. Byrd JC, Dodge RK, Carroll A, Baer MR, Edwards C, Stamberg J et al. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol 1999; 17: 3767–3775.

3. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.

4. Marcucci G, Mrozek K, Ruppert AS, Maharry K, Kolitz JE, Moore JO et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol 2005; 23: 5705–5717.

5. Nishii K, Usui E, Katayama N, F Lorenzo V, Nakase K, Kobayashi T et al. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Leukemia 2003; 17: 731–737.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Core binding factor acute myeloid leukemia: Advances in the heterogeneity of KIT, FLT3, and RAS mutations (Review);Molecular and Clinical Oncology;2020-05-25

2. Morphological characteristics, cytogenetic profile, and outcome of RUNX1‐RUNX1T1 ‐positive acute myeloid leukemia: Experience of an Indian tertiary care center;International Journal of Laboratory Hematology;2019-11-14

3. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia;Chinese Medical Journal;2016-06-05

4. High Expression of c-kit mRNA Predicts Unfavorable Outcome in Adult Patients with t(8;21) Acute Myeloid Leukemia;PLOS ONE;2015-04-10

5. Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy;American Journal of Hematology;2014-08-27